Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BLACNASDAQ:DXRNASDAQ:MDAINASDAQ:MODD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBLACBellevue Life Sciences Acquisition$1.67+15.2%$1.34$3.01▼$13.40$6.75M-0.0820,601 shs216,511 shsDXRDaxor$8.79+0.5%$7.88$6.55▼$10.00$42.52M-0.135,839 shs3,063 shsMDAISpectral AI$2.13+3.9%$1.40$0.82▼$3.25$53.93M0.7855,400 shs211,725 shsMODDModular Medical$0.80-7.7%$0.91$0.68▼$2.65$43.24M0.22210,286 shs84,647 shsA Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBLACBellevue Life Sciences Acquisition+15.17%+27.48%+33.60%+0.60%-84.47%DXRDaxor-5.81%+1.86%+20.52%+7.23%-1.80%MDAISpectral AI-2.84%+19.19%+50.74%+48.55%+19.88%MODDModular Medical+5.06%+3.20%-15.33%-2.20%-47.98%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBLACBellevue Life Sciences AcquisitionN/AN/AN/AN/AN/AN/AN/AN/ADXRDaxor4.0127 of 5 stars3.53.00.00.02.73.30.0MDAISpectral AI3.6514 of 5 stars3.75.00.00.03.33.30.0MODDModular Medical1.8091 of 5 stars0.04.00.00.03.83.30.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBLACBellevue Life Sciences Acquisition 0.00N/AN/AN/ADXRDaxor 3.00Buy$25.00184.41% UpsideMDAISpectral AI 3.33Buy$4.75123.00% UpsideMODDModular Medical 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest BLAC, MODD, MDAI, and DXR Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/2/2025MDAISpectral AIHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$3.50 ➝ $3.503/18/2025MDAISpectral AIHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$3.50 ➝ $3.503/17/2025DXRDaxorAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$24.75 ➝ $25.00(Data available from 6/12/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBLACBellevue Life Sciences AcquisitionN/AN/AN/AN/AN/AN/ADXRDaxor$2.13M19.95N/AN/AN/A∞MDAISpectral AI$29.96M1.80N/AN/A($0.10) per share-21.30MODDModular MedicalN/AN/AN/AN/A$0.25 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBLACBellevue Life Sciences AcquisitionN/AN/A0.00∞N/AN/AN/AN/AN/ADXRDaxorN/AN/A0.00∞N/AN/AN/AN/AN/AMDAISpectral AI-$20.85M-$0.54N/AN/AN/A-40.78%N/A-77.87%N/AMODDModular Medical-$17.47M-$0.53N/A∞N/AN/A-197.97%-162.31%6/19/2025 (Estimated)Latest BLAC, MODD, MDAI, and DXR EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails3/27/2025Q4 2024MDAISpectral AI-$0.13-$0.06+$0.07-$0.41$6.83 million$7.60 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBLACBellevue Life Sciences AcquisitionN/AN/AN/AN/AN/ADXRDaxor$0.030.34%N/AN/AN/AMDAISpectral AIN/AN/AN/AN/AN/AMODDModular MedicalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBLACBellevue Life Sciences AcquisitionN/AN/AN/ADXRDaxorN/AN/AN/AMDAISpectral AIN/A0.730.69MODDModular MedicalN/A5.305.30Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBLACBellevue Life Sciences Acquisition55.30%DXRDaxor1.34%MDAISpectral AI67.08%MODDModular Medical27.47%Insider OwnershipCompanyInsider OwnershipBLACBellevue Life Sciences Acquisition33.67%DXRDaxor59.00%MDAISpectral AI30.70%MODDModular Medical20.46%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBLACBellevue Life Sciences AcquisitionN/A4.04 million2.68 millionNot OptionableDXRDaxor374.84 million1.98 millionNot OptionableMDAISpectral AI8325.32 million8.04 millionNot OptionableMODDModular Medical2054.25 million32.35 millionNot OptionableBLAC, MODD, MDAI, and DXR HeadlinesRecent News About These CompaniesModular Medical adds insulin delivery tech veteran to boardMay 29, 2025 | drugdeliverybusiness.comModular Medical, Inc.: Modular Medical Appoints Industry Veteran Jeff Goldberg to Board of DirectorsMay 29, 2025 | finanznachrichten.deModular Medical Appoints Industry Veteran Jeff Goldberg to Board of DirectorsMay 28, 2025 | accessnewswire.comRegistration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event Titled "Making Diabetes Management Simpler: The New Era of Insulin Therapy" Featuring Modular Medical CEO - Wednesday, May 28, 2025May 27, 2025 | accessnewswire.comModular Medical to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025May 22, 2025 | accessnewswire.comModular Medical files to sell 20.4M shares of common stock for holdersApril 26, 2025 | markets.businessinsider.comManchester Management Co Llc Acquires 156,250 Shares of Modular Medical, Inc. (NASDAQ:MODD) StockMarch 25, 2025 | insidertrades.comModular Medical announces $12M private placementMarch 21, 2025 | drugdeliverybusiness.comModular Medical, Inc.: Modular Medical Announces $12 Million Private PlacementMarch 20, 2025 | finanznachrichten.deModular Medical Announces $12 Million Private PlacementMarch 20, 2025 | accessnewswire.comModular Medical takes step forward in CE mark process for insulin pump techFebruary 3, 2025 | drugdeliverybusiness.comModular Medical Announces BSI Group as Trusted Body for CE Mark ClearanceJanuary 30, 2025 | accessnewswire.comModular Medical, Inc.: Modular Medical Announces Licensing and Partnership Agreement With Nudge BGDecember 19, 2024 | finanznachrichten.deModular Medical Announces Licensing and Partnership Agreement With Nudge BGDecember 19, 2024 | accesswire.comManchester Management Co Llc Buys 21,000 Shares of Modular Medical, Inc. (NASDAQ:MODD) StockDecember 5, 2024 | insidertrades.comModular Medical brings in $8.2MDecember 3, 2024 | drugdeliverybusiness.comModular Medical Announces Conference Call to Provide Business UpdateDecember 3, 2024 | finance.yahoo.comFavourable Signals For Modular Medical: Numerous Insiders Acquired StockDecember 2, 2024 | uk.finance.yahoo.comInsider Buying: Modular Medical, Inc. (NASDAQ:MODD) Director Buys 100,000 Shares of StockNovember 30, 2024 | insidertrades.comManchester Management Co Llc Purchases 166,666 Shares of Modular Medical, Inc. (NASDAQ:MODD) StockNovember 26, 2024 | insidertrades.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Defense Stocks That Will Profit From a Golden DomeBy Chris Markoch | May 30, 2025View 3 Defense Stocks That Will Profit From a Golden DomeAnalysts Think These Stocks Could More Than Double in ValueBy Nathan Reiff | May 23, 2025View Analysts Think These Stocks Could More Than Double in ValueIntel’s Turnaround May Be the Best Bet No One’s WatchingBy Jeffrey Neal Johnson | May 30, 2025View Intel’s Turnaround May Be the Best Bet No One’s WatchingBullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsBy Thomas Hughes | May 27, 2025View Bullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsSuper Micro Computer Stock Finding Upside With NVIDIA's BlackwellBy Gabriel Osorio-Mazilli | May 30, 2025View Super Micro Computer Stock Finding Upside With NVIDIA's BlackwellBLAC, MODD, MDAI, and DXR Company DescriptionsBellevue Life Sciences Acquisition NASDAQ:BLAC$1.67 +0.22 (+15.17%) As of 06/10/2025Bellevue Life Sciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.Daxor NASDAQ:DXR$8.79 +0.04 (+0.46%) As of 03:44 PM EasternDaxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a subsidiary of Estate Of Joseph Feldschuh.Spectral AI NASDAQ:MDAI$2.13 +0.08 (+3.90%) As of 04:00 PM EasternSpectral AI, Inc., an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView System, a predictive analytics platform integrated with the predictive AI-Burn, which combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential and offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention; and DeepView SnapShot M, a handheld, portable, and wireless diagnostic tool, that provides a potential enhanced and expanded use for the government and emergency care, first responders, and potentially home health care professionals. The company is headquartered in Dallas, Texas.Modular Medical NASDAQ:MODD$0.80 -0.07 (-7.71%) As of 04:00 PM EasternModular Medical, Inc. operates as a medical device company. It focuses on the design, development, and commercialization of insulin pumps. It offers MODD1, a two-part patch pump for type-1 and type-2 diabetes. The company is headquartered in San Diego, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Ignore the Noise—Samsara Stock Is Still a Strong Buy Oracle’s Cloud Boom Is Just Getting Started Netflix Sets New Highs—Price Targets Keep Climbing IonQ’s $1B Acquisition and Drug Discovery Leap With NVIDIA Alibaba’s Dip Is a Gift—Here’s the Price That Matters Betting on Disruption: Is Lemonade the Future of Insurance? Starbucks Stock: Culture Fix May Be Key to Long-Term Growth GameStop Turns a Profit, But Core Business Keeps Shrinking Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
